Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are more frequently affected than men. The diagnosis of migraine is primarily based on clinical criteria and the patient’s medical history. To date, there are no disease-specific biomarkers, which is why the exclusion of a secondary cause of headache is crucial for the diagnosis and is included in the main criteria.
Autoren
- Dr. med. Hana You
- Prof. Dr. med. Christoph J. Schankin
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Functional gastrointestinal disorders
Menthacarin for irritable bowel syndrome and stomach
- Lymphoma
Treatment goal: slow progression, improve quality of life
- PancNEN, PancNET & PancNEC
Neuroendocrine tumors of the pancreas
- Heart failure
Interventional treatment of the tricuspid valve
- Lipoprotein(a)
Current and future treatment options
- Lichen sclerosus
Topical corticosteroids still the first choice
- Breast Cancer
On the trail of triple-negative breast cancer
- Headache treatment